Literature DB >> 10344789

Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.

S M Yatin1, M Aksenova, M Aksenov, W R Markesbery, T Aulick, D A Butterfield.   

Abstract

Amyloid beta-peptide (Abeta), the main constituent of senile plaques in Alzheimer's disease (AD) brain, is hypothesized to be a key factor in the neurodegeneration seen in AD. Recently it has been shown that the neurotoxicity of Abeta occurs in conjunction with free-radical oxidative stress associated with the peptide. In the present study, we investigated the temporal relations among the formation of Abeta-associated free radicals, the oxidative damage to, and the activation of antioxidant defense mechanisms in rat embryonic hippocampal neuronal culture subjected to toxic Abeta(25-35). Temporal electron paramagnetic resonance (EPR) spectroscopy results show that synthetic Abeta(25-35) forms free radicals rapidly after solubilization with a high signal intensity at initial time points. At those time points, neuronal toxicity and oxidative stress gradually increase as assessed by reduction of 3-[4,5-dimethylthiazol-2-yl)-2,5-diphenyl] tetrazolium bromide, trypan blue exclusion, formation of reactive oxygen species, and detection of protein carbonyl levels. The latter occurs before neurotoxicity. When the EPR signal intensity of Abeta solution decreases at later time points, neuronal toxicity levels off and remains the same until the end of the experiment. The oxidative-sensitive enzyme creatine kinase (CK) (brain isoform) (CK-BB) content increases at initial points of the Abeta treatment in correlation with the EPR signal to keep the CK activity constant, presumably to overcome the Abeta-induced oxidative insult. CK-BB content returns to normal levels by the end of the experiment. CK activity normalized to CK content implies the presence of inactivated CK molecules during the treatment. Both Mn SOD and Cu/Zn superoxide dismutase (SOD) mRNA levels show robust increases initially, which later return to control level with decreasing oxidative insult. These results are consistent with the notion that Abeta(25-35) promotes a rapid free-radical oxidative stress to neurons, which respond by modulating various oxidative stress-handling genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10344789     DOI: 10.1385/JMN:11:3:183

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells.

Authors:  K E Gridley; P S Green; J W Simpkins
Journal:  Brain Res       Date:  1997-12-05       Impact factor: 3.252

2.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

Authors:  C A Davies; D M Mann; P Q Sumpter; P O Yates
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

3.  Oxidative modification of glutamine synthetase by amyloid beta peptide.

Authors:  M Y Aksenov; M V Aksenova; J M Carney; D A Butterfield
Journal:  Free Radic Res       Date:  1997-09

4.  Mitochondrial regulation of superoxide by Ca2+: an alternate mechanism for the cardiotoxicity of doxorubicin.

Authors:  E Chacon; D Acosta
Journal:  Toxicol Appl Pharmacol       Date:  1991-01       Impact factor: 4.219

Review 5.  Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis.

Authors:  A L Friedlich; L L Butcher
Journal:  Neurobiol Aging       Date:  1994 Jul-Aug       Impact factor: 4.673

6.  beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

Authors:  D A Butterfield; K Hensley; M Harris; M Mattson; J Carney
Journal:  Biochem Biophys Res Commun       Date:  1994-04-29       Impact factor: 3.575

7.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Vitamin E protects nerve cells from amyloid beta protein toxicity.

Authors:  C Behl; J Davis; G M Cole; D Schubert
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

10.  beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

Authors:  A J Bruce; B Malfroy; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more
  11 in total

Review 1.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

2.  Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans.

Authors:  Heather C Kuiper; Richard S Bruno; Maret G Traber; Jan F Stevens
Journal:  Free Radic Biol Med       Date:  2011-01-12       Impact factor: 7.376

3.  Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract.

Authors:  Gregory J Brewer; John R Torricelli; Amanda L Lindsey; Elizabeth Z Kunz; A Neuman; Derek R Fisher; James A Joseph
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

4.  Evidence for natural antisense transcript-mediated inhibition of microRNA function.

Authors:  Mohammad Ali Faghihi; Ming Zhang; Jia Huang; Farzaneh Modarresi; Marcel P Van der Brug; Michael A Nalls; Mark R Cookson; Georges St-Laurent; Claes Wahlestedt
Journal:  Genome Biol       Date:  2010-05-27       Impact factor: 13.583

Review 5.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

6.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.

Authors:  Mohammad Ali Faghihi; Farzaneh Modarresi; Ahmad M Khalil; Douglas E Wood; Barbara G Sahagan; Todd E Morgan; Caleb E Finch; Georges St Laurent; Paul J Kenny; Claes Wahlestedt
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

Review 7.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29

Review 8.  Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  APP Function and Lipids: A Bidirectional Link.

Authors:  Marcus O W Grimm; Janine Mett; Heike S Grimm; Tobias Hartmann
Journal:  Front Mol Neurosci       Date:  2017-03-10       Impact factor: 5.639

Review 10.  Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.